investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

CHARACTERIZATION AND TARGETED THERAPY OF T-ALL DEFICIENT FOR PTEN AND INK4A/ARF

M. James You

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Related projects

Andrew A Lane

Targeting Chromatin Modifications in Leukemia with Trisomy 21

Leukaemia

Hiroaki Mitsuya

Development of Novel Agents Active against Hepatitis B Virus

Leukaemia

Pathology

Katy Rezvani

Curative Cell-based Therapies for Chronic Lymphocytic Leukemia

Leukaemia

Hematology and hematologic malignancies

Joseph H Antin

A Randomized Trial of Tac/MTX/bortezomib vs Tac/MTXplacebo in Allogeneic HSCT

Leukaemia

James Kochenderfer

Autologous T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor

Leukaemia

Hematology and hematologic malignancies

Xuefang Cao

Targeting Granzyme B to Separate GVH from GVL Responses

Leukaemia

Kenneth Lynn Wright

Natural Killer Cell Regulation by PRDM1 and IRF4/8

Leukaemia

David Baltimore

MicroRNA Function in the Immune System

Leukaemia

Ross L Levine

Role of TET2 mutations in malignant transformation and acute myeloid leukemia

Leukaemia